| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/18/2015 | EP2836516A1 Anti-adamts-5 antibody, derivatives and uses thereof |
| 02/18/2015 | EP2836515A1 Low acidic species compositions and methods for producing and using the same |
| 02/18/2015 | EP2836514A1 Tiki inhibitors |
| 02/18/2015 | EP2836513A1 Modulated lysine variant species compositions and methods for producing and using the same |
| 02/18/2015 | EP2836512A2 Improved antibody light chains |
| 02/18/2015 | EP2836507A2 Sortase- modified vhh domains and uses thereof |
| 02/18/2015 | EP2836239A1 Chimeric antigen receptors targeting b-cell maturation antigen |
| 02/17/2015 | US8957195 Anti-CD19 antibodies with reduced immunogenicity |
| 02/17/2015 | US8957194 1B20 PCSK9 antagonists |
| 02/17/2015 | US8957193 Polynucleotides encoding anti-CD40 antibodies |
| 02/17/2015 | US8957190 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto |
| 02/17/2015 | US8957188 Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same |
| 02/17/2015 | US8957187 Binding polypeptides and uses thereof |
| 02/17/2015 | US8956869 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same |
| 02/17/2015 | US8956867 Method for culturing stem cells |
| 02/17/2015 | US8956832 Cells expressing anti-GD2 antibodies and methods related thereto |
| 02/17/2015 | US8956831 Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α |
| 02/17/2015 | US8956825 Intranuclear protein transduction through a nucleoside salvage pathway |
| 02/17/2015 | US8956818 Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases |
| 02/17/2015 | US8956811 Diagnosis of malignant neoplasms using anti-Notch3 antibodies |
| 02/17/2015 | US8956627 Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates |
| 02/17/2015 | US8956623 Recombinant fusion interferon for animals |
| 02/17/2015 | US8956620 Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine |
| 02/17/2015 | US8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients |
| 02/17/2015 | US8956616 Constructs binding to phosphatidylserine and their use in disease treatment |
| 02/17/2015 | US8956615 Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same |
| 02/17/2015 | US8956614 BACE1 inhibitory antibodies |
| 02/17/2015 | US8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker |
| 02/17/2015 | US8956609 Roles for Dual Endothelin-1/Angiotensin II Receptor (Dear) in hypertension and angiogenesis |
| 02/17/2015 | US8956608 Method for treating sarcopenia using antagonist antibodies against GDF-8 |
| 02/17/2015 | US8956607 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) |
| 02/17/2015 | CA2635623C Anti-cd19 antibodies with reduced immunogenicity |
| 02/17/2015 | CA2583061C Antibody production method |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2506331C Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/17/2015 | CA2501786C Inhibition of il-17 production |
| 02/17/2015 | CA2385745C Methods of administering anti-tnf.alpha. antibodies |
| 02/12/2015 | WO2015021308A1 Assays for timp2 having improved performance in biological samples |
| 02/12/2015 | WO2015021143A1 Metal ion sensors and methods of detecting metal ions |
| 02/12/2015 | WO2015021108A1 Compositions and methods for detecting cortisol |
| 02/12/2015 | WO2015020212A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/12/2015 | WO2015020193A1 Novel anti-human tslp receptor antibody |
| 02/12/2015 | WO2015020159A1 Protein, method for manufacturing same, and method for evaluating protein activity |
| 02/12/2015 | WO2015019979A1 Biomarker related to schizophrenia |
| 02/12/2015 | WO2015019230A1 Bag3 receptor binding molecules for use as a medicament |
| 02/12/2015 | WO2015018832A1 Expression constructs and methods for expressing polypeptides in eukaryotic cells |
| 02/12/2015 | WO2015018529A1 Combined pharmaceutical composition |
| 02/12/2015 | WO2015018528A1 Il-15 and il-15raplha sushi domain based modulokines |
| 02/12/2015 | WO2015018527A1 ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII |
| 02/12/2015 | WO2015018421A1 Antibodies, compounds and derivatives thereof for use in the treatment of male infertility |
| 02/12/2015 | WO2015018331A1 Minicircle dna recombinant parental plasmid having genetically engineered antibody gene expression cassette, a minicircle dna having the expression cassette, and applications |
| 02/12/2015 | WO2015018306A1 Bispecific antibodies |
| 02/12/2015 | WO2015017900A1 An antibody therapy for amyloid beta disease |
| 02/12/2015 | US20150047065 Novel binding molecules with antitumoral activity |
| 02/12/2015 | US20150047060 Transgenic animal model of mood disorders |
| 02/12/2015 | US20150047059 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 02/12/2015 | US20150045542 Human antibodies that bind human tnf-alpha and methods of preparing the same |
| 02/12/2015 | US20150045541 Antibodies for identifying and/or isolating at least one cell population |
| 02/12/2015 | US20150045540 Multispecific stacked variable domain binding proteins |
| 02/12/2015 | US20150045470 Antibody purification method, and carrier for use in purification of antibody |
| 02/12/2015 | US20150044722 Siglec-15 antibodies in treating bone loss-related disease |
| 02/12/2015 | US20150044704 Monoclonal antibodies and diagnostic uses thereof |
| 02/12/2015 | US20150044703 Methods and compositions for detecting endometrial or ovarian cancer |
| 02/12/2015 | US20150044700 Anti-Gap43 Antibody |
| 02/12/2015 | US20150044694 Engineered antibody-nanoparticle conjugates |
| 02/12/2015 | US20150044239 Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms |
| 02/12/2015 | US20150044238 Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the c-terminus |
| 02/12/2015 | US20150044237 Chimeric molecule involving oligomerized fasl extracellular domain |
| 02/12/2015 | US20150044236 Carrier immunoglobulins |
| 02/12/2015 | US20150044235 Carrier immunoglobulins |
| 02/12/2015 | US20150044234 Menainv and cancer invasion and metastasis |
| 02/12/2015 | US20150044233 Ganglioside gd2 as a marker and target on cancer stem cells |
| 02/12/2015 | US20150044232 Markers for the responsiveness to anti-cd44 antibodies |
| 02/12/2015 | US20150044231 Therapeutic Antibodies |
| 02/12/2015 | US20150044230 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044229 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044226 Anti-Phospholipase D4 Antibody |
| 02/12/2015 | US20150044225 Human Anti-Human Influenza Virus Antibody |
| 02/12/2015 | US20150044224 Materials and methods for differential treatment of cancer |
| 02/12/2015 | US20150044223 Combination drug therapy for the treatment of solid tumors |
| 02/12/2015 | US20150044222 Interferon alpha-induced pharmacodynamic markers and uses thereof |
| 02/12/2015 | US20150044221 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/12/2015 | US20150044220 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| 02/12/2015 | US20150044219 Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases |
| 02/12/2015 | US20150044218 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 02/12/2015 | US20150044216 Bispecific antibodies |
| 02/12/2015 | US20150044215 Pseudomonas aeruginosa pcrv binding single variable domain antibodies |
| 02/12/2015 | US20150044214 Bispecific, tetravalent antigen binding proteins |
| 02/12/2015 | US20150044213 Protein sustained-release injectable formulation |
| 02/12/2015 | US20150044212 Antibodies Directed to GPNMB and Uses Thereof |
| 02/12/2015 | US20150044210 Modified microbial toxin receptor for delivering agents into cells |
| 02/12/2015 | US20150044209 SOLUBLE IGF RECEPTOR Fc FUSION PROTEINS AND USES THEREOF |
| 02/12/2015 | US20150044208 Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics |
| 02/12/2015 | US20150044207 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia |
| 02/12/2015 | US20150044206 Immunoglobulin formulation and method of preparation thereof |
| 02/12/2015 | US20150044205 Compositions and method for treating compliment-associated conditions |
| 02/12/2015 | US20150044204 Methods for improving asthma symptoms using benralizumab |
| 02/12/2015 | US20150044203 Methods For Increasing Forced Expiratory Volume In Asthmatics Using Benralizumab |
| 02/12/2015 | US20150044202 Methods for reducing exacerbation rates of asthma using benralizumab |
| 02/12/2015 | US20150044201 Cyclon expression for the identification and control of cancer cells |